Tim Rudolphi

Tim has 30 years of pharmaceutical and healthcare experience with a diverse background in sales, global and US marketing, commercial operations, strategic planning, and business development. Most recently, Tim was Chief Business Officer at Aprecia Pharmaceuticals, the leader in 3-D printing of pharmaceutical drug products. Prior, Tim helped build Takeda Pharmaceuticals, starting with the company in 1999. He took on increasing roles of responsibility, including leading the US Sales Managed Markets, Marketing, and BD teams. Tim has extensive experience bringing GI drugs to market including Amitiza, Prevacid, Dexilant, and Entyvio